LogicBio Therapeutics (LOGC) Announces Proposed Common Offering

Go back to LogicBio Therapeutics (LOGC) Announces Proposed Common Offering

LogicBio Therapeutics (LOGC) Prices 7M Share Public Offering of Common Stock at $6/Each

October 1, 2020 9:12 AM UTC

LogicBio Therapeutics, Inc. (Nasdaq: LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today announced the pricing of its previously announced underwritten public offering of 7,000,000 shares of common stock at a price to the public of $6.00 per share. Gross proceeds to LogicBio from the offering are... More